Non-Small Cell Lung Cancer

About Non-Small Cell Lung Cancer Treatment and Genomic Health's Products in Development

Lung cancer is a condition where there is uncontrolled growth of cells in the lungs. It is the most common cause of cancer-related death in both men and women. Exposure to tobacco smoke is by far the most common cause of lung cancer, but lung cancer diagnosis is not limited to smokers. The term "non-small cell lung cancer" refers to the appearance of the cancer cells under the microscope (another type of lung cancer is known as "small cell lung cancer" and is treated differently). Non-small cell lung cancer includes adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Non-small cell lung cancer is the most common kind of lung cancer. Current lung cancer treatments include surgery, chemotherapy and/or radiation. A test which would provide insight into the individual biology and behavior following diagnosis is greatly needed to better inform treatment planning for lung cancer patients and their physicians. Genomic Health is working to develop such tests.

Learn more about additional Genomic Health products in development:

• Breast Cancer
• Colon Cancer
• Prostate Cancer
• Renal Cancer
• Melanoma

For more information about lung cancer diagnosis, visit the National Cancer Institute's Lung Cancer page or the non-profit group lungcancer.org.

Relevant Presentations
2003 ASCO Annual Meeting—Chicago, IL

Abstract #763: Oral Presentation
Quantitative Gene Expression in Non-Small Cell Lung Cancer from Paraffin-Embedded Tissue Specimens: Predicting Response to Gefitinib, an EGFR Kinase Inhibitor
RB Natale, S Shak, N Aronson, S Averbuch, W Fox, D Luthringer, K Clark, J Baker, M Cronin, DB Agus

1. Mattson Jack, CancerMPact November 2010 (2011 incidence).
2. Company figure adapted from MattsonJack, CancerMpact, November 2010 (2011 incidence).
3. American Cancer Society 2007 Statistics. Available at: http://www.cancer.org/Research/CancerFactsFigures/index. Accessed July 22, 2008.